Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

Clinical Case Reports

Saurabh J Bhave¹  Mita Roychowdhury¹  Manthan Kathrotiya¹  Vivek S Radhakrishnan¹  Jeevan Kumar¹  Mammen Chandy¹  Reena Nair¹  Jayanta Das²  Indu Arun³ 

[1] Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India;Nuclear Medicine Tata Medical Center Kolkata India;Pathology Tata Medical Center Kolkata India;

关键词: daratumumab;    haploidentical transplantation;    novel therapies;    plasmablastic lymphoma;    relapse;   

DOI  :  10.1002/ccr3.3673

来源: DOAJ

【 摘 要 】

Abstract This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

【 授权许可】

Unknown